Your browser doesn't support javascript.
loading
Association of Immediate Postpartum Etonogestrel Implant Insertion and Venous Thromboembolism.
Floyd, Jessica L; Beasley, Anitra D; Swaim, Laurie S; Turrentine, Mark A; Nijjar, J Biba.
Afiliación
  • Floyd JL; Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas.
Obstet Gynecol ; 135(6): 1275-1280, 2020 06.
Article en En | MEDLINE | ID: mdl-32459418
ABSTRACT

OBJECTIVE:

To estimate the rate of readmissions for postpartum venous thromboembolism (VTE) during the first 30 days postdelivery between women with and without the immediate postpartum insertion of the etonogestrel contraceptive implant.

METHODS:

The Nationwide Readmissions Database from 2016 was used to identify women with a singleton delivery, immediate postpartum insertion of the etonogestrel contraceptive implant, and readmission for VTE within 30 days of discharge. Those with a prior history of VTE or anticoagulant therapy were excluded. These women were compared with the number of women readmitted within 30 days for VTE who did not have the contraceptive implant placed during delivery admission.

RESULTS:

Of 3,387,120 deliveries, 8,369 women underwent etonogestrel contraceptive implant placement during the delivery admission. There was no difference identified in the rate of readmission for VTE between exposed and unexposed women. Of these, seven had received a postpartum etonogestrel contraceptive implant (0.85/1,000; 95% CI 0.22-1.45/1,000 deliveries), compared with 1,192 without an etonogestrel contraceptive implant (0.35/1,000; 95% CI 0.33-0.37/1,000 deliveries); odds ratio (OR) 2.41; 95% CI 0.58-9.89. The rates of diabetes, thrombophilia, systemic lupus erythematosus, and cesarean birth did not differ between groups. Women who underwent etonogestrel contraceptive implant placement were younger and were more likely to have government-sponsored health insurance, a smoking history, hypertension, peripartum infection, or postpartum hemorrhage than women who did not receive an etonogestrel contraceptive implant (P<.001). After adjusting for these confounders, there remained no difference in rates of VTE, adjusted OR 1.81; 95% CI 0.44-7.45.

CONCLUSION:

The immediate postpartum placement of the etonogestrel contraceptive implant was not associated with an increased rate of VTE; however, our sample size was underpowered to determine no difference.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 5_ODS3_mortalidade_materna Problema de salud: 5_maternal_care Asunto principal: Readmisión del Paciente / Desogestrel / Anticoncepción / Anticonceptivos Femeninos / Tromboembolia Venosa Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans País/Región como asunto: America do norte Idioma: En Revista: Obstet Gynecol Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 5_ODS3_mortalidade_materna Problema de salud: 5_maternal_care Asunto principal: Readmisión del Paciente / Desogestrel / Anticoncepción / Anticonceptivos Femeninos / Tromboembolia Venosa Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans País/Región como asunto: America do norte Idioma: En Revista: Obstet Gynecol Año: 2020 Tipo del documento: Article
...